Pfizer’s investigational drug for sickle cell disease failed in a critical Phase III trial. The company announced that the ...

Pfizer is advancing research and building a comprehensive "toolbox" for Vietnamese patients, combining innovative vaccines, ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

The toughest hillclimb in the world returned under picture-perfect conditions, and Ian Boswell and Illi Gardner turned in ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...

The toughest hillclimb in the world returned under picture-perfect conditions, and Ian Boswell and Illi Gardner turned in ...

O’Reilly Auto Parts will become the title sponsor for NASCAR’s second-tier national series when the Xfinity Series is renamed ...

The IVES AI 30 list is a group of 30 tech companies analysts led by Daniel Ives believe will define the future of the AI ...

Mercedes-Benz USA (MBUSA) today announced the appointment of Greg Gates as Vice President of Network Development, effective ...

Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain ...

This is the latest hit for Pfizer’s sickle cell disease portfolio after pulling Oxbryta from the market in 2024.